- Home
- ACXP vs GSIW Comparison
ACXP vs GSIW Comparison
Compare ACXP & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- GSIW
- Stock Information
- Founded
- ACXP 2017
- GSIW 2016
- Country
- ACXP United States
- GSIW Hong Kong
- Employees
- ACXP N/A
- GSIW N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- GSIW
- Sector
- ACXP Health Care
- GSIW
- Exchange
- ACXP Nasdaq
- GSIW Nasdaq
- Market Cap
- ACXP 8.4M
- GSIW 8.3M
- IPO Year
- ACXP 2021
- GSIW 2023
- Fundamental
- Price
- ACXP $0.38
- GSIW $0.75
- Analyst Decision
- ACXP Strong Buy
- GSIW
- Analyst Count
- ACXP 2
- GSIW 0
- Target Price
- ACXP $10.00
- GSIW N/A
- AVG Volume (30 Days)
- ACXP 142.6K
- GSIW 1.9M
- Earning Date
- ACXP 05-13-2025
- GSIW 12-31-2024
- Dividend Yield
- ACXP N/A
- GSIW N/A
- EPS Growth
- ACXP N/A
- GSIW N/A
- EPS
- ACXP N/A
- GSIW N/A
- Revenue
- ACXP N/A
- GSIW $1,313,795.00
- Revenue This Year
- ACXP N/A
- GSIW N/A
- Revenue Next Year
- ACXP N/A
- GSIW N/A
- P/E Ratio
- ACXP N/A
- GSIW N/A
- Revenue Growth
- ACXP N/A
- GSIW N/A
- 52 Week Low
- ACXP $0.30
- GSIW $0.35
- 52 Week High
- ACXP $3.33
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- ACXP 46.83
- GSIW 64.36
- Support Level
- ACXP $0.36
- GSIW $0.43
- Resistance Level
- ACXP $0.43
- GSIW $1.03
- Average True Range (ATR)
- ACXP 0.03
- GSIW 0.09
- MACD
- ACXP 0.00
- GSIW 0.03
- Stochastic Oscillator
- ACXP 37.55
- GSIW 41.91
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.